GR3004912T3 - - Google Patents

Info

Publication number
GR3004912T3
GR3004912T3 GR920401262T GR920401262T GR3004912T3 GR 3004912 T3 GR3004912 T3 GR 3004912T3 GR 920401262 T GR920401262 T GR 920401262T GR 920401262 T GR920401262 T GR 920401262T GR 3004912 T3 GR3004912 T3 GR 3004912T3
Authority
GR
Greece
Application number
GR920401262T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK503386A external-priority patent/DK503386D0/da
Priority claimed from DK356987A external-priority patent/DK356987D0/da
Application filed filed Critical
Publication of GR3004912T3 publication Critical patent/GR3004912T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
GR920401262T 1986-10-20 1992-06-11 GR3004912T3 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK503386A DK503386D0 (da) 1986-10-20 1986-10-20 Peptidpraeparater
DK356987A DK356987D0 (cg-RX-API-DMAC7.html) 1987-07-10 1987-07-10

Publications (1)

Publication Number Publication Date
GR3004912T3 true GR3004912T3 (cg-RX-API-DMAC7.html) 1993-04-28

Family

ID=26067111

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401262T GR3004912T3 (cg-RX-API-DMAC7.html) 1986-10-20 1992-06-11

Country Status (18)

Country Link
US (1) US5070186A (cg-RX-API-DMAC7.html)
EP (1) EP0265213B1 (cg-RX-API-DMAC7.html)
KR (1) KR880004819A (cg-RX-API-DMAC7.html)
CN (1) CN87107049A (cg-RX-API-DMAC7.html)
AU (1) AU616381B2 (cg-RX-API-DMAC7.html)
CA (1) CA1316819C (cg-RX-API-DMAC7.html)
DE (1) DE3778287D1 (cg-RX-API-DMAC7.html)
ES (1) ES2033871T3 (cg-RX-API-DMAC7.html)
FI (1) FI86254C (cg-RX-API-DMAC7.html)
GR (1) GR3004912T3 (cg-RX-API-DMAC7.html)
HU (1) HU201475B (cg-RX-API-DMAC7.html)
IE (1) IE60264B1 (cg-RX-API-DMAC7.html)
IL (1) IL84203A (cg-RX-API-DMAC7.html)
NO (1) NO170754C (cg-RX-API-DMAC7.html)
NZ (1) NZ222214A (cg-RX-API-DMAC7.html)
PH (1) PH23446A (cg-RX-API-DMAC7.html)
PT (1) PT85949B (cg-RX-API-DMAC7.html)
YU (1) YU46665B (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
AR002976A1 (es) * 1995-03-31 1998-05-27 Lilly Co Eli Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
DE69924232D1 (de) * 1998-01-09 2005-04-21 Novo Nordisk As Stabilisierte insulin-zubereitungen
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
CA2457949A1 (en) * 2001-08-27 2003-03-06 Novo-Nordisk A/S A cartridge and a medical delivery system accommodating such a cartridge
KR20050094832A (ko) * 2002-12-31 2005-09-28 알투스 파마슈티컬스 인코포레이티드 단백질 결정과 이온성 중합체를 함유하는 복합체
DK1581251T3 (da) * 2002-12-31 2016-06-27 Althea Tech Inc Krystaller af humant væksthormon og fremgangsmåder til fremstilling deraf
EP1976551A4 (en) * 2005-12-23 2009-12-30 Altus Pharmaceuticals Inc COMPOSITIONS COMPRISING COMPLEX PROTEIN CRYSTALS BY POLYCATIONS AND PROCESSING METHOD THEREOF
CN101573133B (zh) 2006-07-31 2014-08-27 诺沃-诺迪斯克有限公司 Peg化延长的胰岛素
CN101541830A (zh) 2006-09-22 2009-09-23 诺沃-诺迪斯克有限公司 蛋白酶抗性的胰岛素类似物
WO2008132224A2 (en) 2007-04-30 2008-11-06 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
JP2010525033A (ja) * 2007-04-30 2010-07-22 ノボ・ノルデイスク・エー／エス 高濃縮のインスリン溶液及び組成物
CN101970477B (zh) 2008-03-14 2014-12-31 诺沃-诺迪斯克有限公司 蛋白酶稳定的胰岛素类似物
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
PH12011502708B1 (en) 2009-07-06 2017-11-10 Sanofi Aventis Deutschland Insulin preparations containing methionine
JP5832439B2 (ja) 2009-11-13 2015-12-16 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｇｌｐ−１アゴニスト、インスリン及びメチオニンを含む薬学的組成物
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
US8637458B2 (en) * 2010-05-12 2014-01-28 Biodel Inc. Insulin with a stable basal release profile
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
CN103179978A (zh) 2010-08-30 2013-06-26 赛诺菲-安万特德国有限公司 Ave0010用于制造供治疗2型糖尿病用的药物的用途
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
JP6367115B2 (ja) 2011-08-29 2018-08-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ２型糖尿病患者の血糖コントロールに使用する組合せ医薬
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
EP2836508B1 (en) 2012-04-11 2016-06-29 Novo Nordisk A/S Insulin formulations
US9399065B2 (en) 2012-04-16 2016-07-26 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
US9381247B2 (en) * 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
EP3517122A1 (en) 2013-04-03 2019-07-31 Sanofi Treatment of diabetes mellitus by long-acting formulations of insulins
CA2926701A1 (en) 2013-10-07 2015-04-16 Novo Nordisk A/S Novel derivative of an insulin analogue
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2076082A (en) * 1935-04-08 1937-04-06 Nordisk Insulinlab Therapeutic product and process
US2179384A (en) * 1937-04-05 1939-11-07 Univ Alberta Therapeutic composition and process of making it
US2190134A (en) * 1939-06-09 1940-02-13 Norton Co Grinding machine
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2801953A (en) * 1952-02-28 1957-08-06 Hoechst Ag Process of preparing crystallized insulin preparations
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
DK98342C (da) * 1959-06-16 1964-03-31 Henry Marinus Dr Christensen Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
US3868358A (en) * 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product
GB1426061A (en) * 1972-12-28 1976-02-25 Ici Ltd Polypeptides
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
AU550068B2 (en) * 1981-03-10 1986-02-27 Novo Nordisk A/S Zinc insulin stabilized with calcium or magnesium salts
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production

Also Published As

Publication number Publication date
PT85949B (pt) 1990-07-31
EP0265213A2 (en) 1988-04-27
YU191887A (en) 1989-04-30
FI874596A0 (fi) 1987-10-19
YU46665B (sh) 1994-01-20
PH23446A (en) 1989-08-07
US5070186A (en) 1991-12-03
FI874596L (fi) 1988-04-21
HU201475B (en) 1990-11-28
PT85949A (en) 1987-11-01
NO874347D0 (no) 1987-10-19
ES2033871T3 (es) 1993-04-01
CN87107049A (zh) 1988-07-06
IL84203A (en) 1993-04-04
EP0265213B1 (en) 1992-04-15
IE60264B1 (en) 1994-06-29
NO170754C (no) 1992-12-02
HUT46232A (en) 1988-10-28
IE872799L (en) 1988-04-20
KR880004819A (ko) 1988-06-27
FI86254B (fi) 1992-04-30
NO874347L (no) 1988-04-21
EP0265213A3 (en) 1988-11-09
FI86254C (fi) 1992-08-10
CA1316819C (en) 1993-04-27
AU616381B2 (en) 1991-10-31
NZ222214A (en) 1989-11-28
NO170754B (no) 1992-08-24
DE3778287D1 (de) 1992-05-21
AU7990787A (en) 1988-04-21

Similar Documents

Publication Publication Date Title
IN167102B (cg-RX-API-DMAC7.html)
AU7131891A (cg-RX-API-DMAC7.html)
GR3006472T3 (cg-RX-API-DMAC7.html)
FR2602942B1 (cg-RX-API-DMAC7.html)
IN170454B (cg-RX-API-DMAC7.html)
FR2606822B1 (cg-RX-API-DMAC7.html)
AU7354491A (cg-RX-API-DMAC7.html)
AU6161186A (cg-RX-API-DMAC7.html)
AU6014586A (cg-RX-API-DMAC7.html)
AU5783386A (cg-RX-API-DMAC7.html)
AU6098786A (cg-RX-API-DMAC7.html)
AU5173485A (cg-RX-API-DMAC7.html)
AU5444986A (cg-RX-API-DMAC7.html)
AU4910985A (cg-RX-API-DMAC7.html)
AU5655786A (cg-RX-API-DMAC7.html)
AU5614386A (cg-RX-API-DMAC7.html)
AU5614486A (cg-RX-API-DMAC7.html)
AU5130385A (cg-RX-API-DMAC7.html)
AU5703286A (cg-RX-API-DMAC7.html)
AU5348186A (cg-RX-API-DMAC7.html)
AU6211586A (cg-RX-API-DMAC7.html)
AU4375585A (cg-RX-API-DMAC7.html)
AU5227086A (cg-RX-API-DMAC7.html)
AU5329886A (cg-RX-API-DMAC7.html)
AU6011386A (cg-RX-API-DMAC7.html)